SGMO Sangamo Therapeutics, Inc.

Fundamentals / CIK 0001001233 / USD
Other share classes on CIK 0001001233: SGMOQ

Sangamo Therapeutics, Inc. reported $34.56M in revenue and a net loss of $123.3M for the trailing twelve months ended March 31, 2026 (down 77.6% year over year), with a -357.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SGMO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$200.9M$100.5M$0-$256.1MFY 2016 Revenue: $19.39MFY 2016 Net Income: -$71.66M2016FY 2017 Revenue: $36.57MFY 2017 Net Income: -$54.57M2017FY 2018 Revenue: $84.45MFY 2018 Net Income: -$68.33M2018FY 2019 Revenue: $102.4MFY 2019 Net Income: -$95.19M2019FY 2020 Revenue: $118.2MFY 2020 Net Income: -$121.0M2020FY 2021 Revenue: $110.7MFY 2021 Net Income: -$178.3M2021FY 2022 Revenue: $111.3MFY 2022 Net Income: -$192.3M2022FY 2023 Revenue: $176.2MFY 2023 Net Income: -$257.8M2023FY 2024 Revenue: $57.80MFY 2024 Net Income: -$97.94M2024FY 2025 Revenue: $39.55MFY 2025 Net Income: -$122.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $39.55M $57.80M $176.2M $111.3M $110.7M $118.2M $102.4M $84.45M $36.57M $19.39M
Research & Development $112.7M $111.5M $234.1M $249.9M $230.8M $180.6M $145.9M $114.9M $65.73M $65.62M
Total Operating Expenses $160.8M $161.8M $450.2M $312.6M $294.0M $247.7M $207.6M $161.6M $92.93M $91.95M
Operating Income -$121.2M -$104.0M -$274.0M -$201.3M -$183.3M -$129.6M -$105.2M -$77.15M -$56.36M -$72.56M
EBITDA -$117.3M -$98.86M -$258.9M -$189.2M -$173.9M -$123.9M -$101.2M -$74.79M -$54.86M -$71.56M
Interest Income $1.30M $1.51M -- -- -- -- -- -- -- --
Income Before Tax -$123.5M -$98.11M -$262.9M -$191.8M -$178.0M -$120.8M -$95.42M -$68.89M -$54.57M -$71.67M
Income Tax Expense -$568K -$167K -$5.07M $429K $306K $345K $0 $0 $0 -$14K
Net Income -$122.9M -$97.94M -$257.8M -$192.3M -$178.3M -$121.0M -$95.19M -$68.33M -$54.57M -$71.66M
Basic EPS -$0.44 -$0.49 -$1.48 -$1.25 -$1.23 -$0.90 -$0.85 -$0.70 -$0.70 -$1.02
Diluted EPS -$0.44 -$0.49 -$1.48 -$1.25 -$1.23 -$0.90 -$0.85 -$0.70 -$0.70 -$1.02
Basic Shares Outstanding 280.2M 201.7M 174.4M 154.3M 144.6M 134.4M 112.1M 96.9M 78.1M 70.6M
Diluted Shares Outstanding 280.2M 201.7M 174.4M 154.3M 144.6M 134.4M 112.1M 96.9M 78.1M 70.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue $1.44M $14.23M $581K $18.31M $6.44M $7.55M $49.41M $356K
Research & Development $26.57M $31.44M $28.14M $27.08M $26.01M $23.68M $27.73M $24.22M
Total Operating Expenses $33.39M $52.43M $36.13M $36.16M $36.06M $33.54M $38.78M $37.44M
Operating Income -$31.95M -$38.20M -$35.55M -$17.86M -$29.63M -$25.99M $10.63M -$37.08M
EBITDA -$31.23M -$37.24M -$34.56M -$16.86M -$28.61M -$24.75M $11.85M -$35.84M
Income Before Tax -$31.00M -$37.97M -$35.09M -$19.96M -$30.48M -$23.82M $10.76M -$36.05M
Income Tax Expense $0 -$553K -$161K $27K $119K -$427K $88K $74K
Net Income -$31.00M -$37.42M -$34.93M -$19.99M -$30.60M -$23.40M $10.67M -$36.13M
Basic EPS -$0.08 -- -$0.11 -$0.08 -$0.14 -- $0.05 -$0.18
Diluted EPS -$0.08 -- -$0.11 -$0.08 -$0.14 -- $0.04 -$0.18
Basic Shares Outstanding 389.6M -- 304.3M 256.9M 220.3M -- 208.3M 203.9M
Diluted Shares Outstanding 389.6M -- 304.3M 256.9M 220.3M -- 214.3M 203.9M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $20.95M $41.92M $45.20M $100.4M $178.9M $131.3M $80.43M $140.4M $49.83M $22.06M
Short-Term Investments -- -- -- $177.2M $197.7M $510.1M $282.0M $259.7M $193.5M --
Cash & Short-Term Investments $20.95M $41.92M $81.00M $307.5M $376.5M $641.4M $362.5M $400.1M $243.3M $22.06M
Accounts Receivable, Net $371K $526K $923K $3.68M $6.01M $5.22M $36.91M $4.67M $3.34M $4.97M
Total Current Assets $35.83M $51.69M $94.33M $300.3M $398.8M $659.7M $405.5M $410.5M $248.4M $149.6M
Property, Plant & Equipment, Net $11.04M $17.89M $26.87M $63.53M $51.52M $41.32M $29.93M $78.72M $31.07M $6.56M
Goodwill -- $0 $0 $37.55M $39.70M $42.80M $39.27M $40.04M $1.58M $1.58M
Intangible Assets -- $0 $0 $50.73M $53.76M $58.13M $53.16M $54.24M $0 --
Long-Term Investments -- -- -- $29.84M $88.17M $50.53M $21.83M $0 $1.01M --
Other Non-Current Assets $871K $879K $1.26M $17.02M $15.32M $13.56M $9.07M $3.36M $1.18M $169K
Total Non-Current Assets $23.91M $49.94M $70.99M $262.2M $323.2M $278.9M $232.0M $179.9M $38.34M $8.31M
Total Assets $59.74M $101.6M $165.3M $562.5M $721.9M $938.5M $637.5M $590.4M $286.7M $157.9M
Accounts Payable $14.44M $15.48M $15.26M $22.42M $9.76M $12.55M $6.67M $3.35M $16K $2.58M
Deferred Revenue (Current) $899K $7.56M $0 $51.78M $85.71M $91.64M $38.71M $47.56M $28.34M $4.14M
Total Current Liabilities $42.47M $45.80M $47.73M $111.7M $127.9M $143.5M $69.87M $78.51M $44.86M $13.29M
Deferred Revenue (Non-Current) $5.87M $5.87M $0 $109.4M $166.8M $245.0M $81.43M $108.3M $29.24M $4.46M
Other Non-Current Liabilities $580K $933K $1.19M $1.21M $1.22M $7.01M $5.71M $1.96M -- --
Total Non-Current Liabilities $31.55M $33.06M $34.70M $155.8M $218.7M $297.6M $134.9M $144.6M $53.98M $8.40M
Total Liabilities $74.01M $78.86M $82.43M $267.6M $346.6M $441.2M $204.8M $223.1M $98.84M $21.70M
Total Debt (incl. Leases) $26.80M $30.57M $38.10M $43.11M $48.08M $42.09M $44.41M -- -- --
Common Stock $3.51M $2.13M $1.78M $1.67M $1.46M $1.42M $1.16M $1.02M $856K $709K
Retained Earnings -$1.63B -$1.50B -$1.41B -$1.15B -$956.3M -$778.0M -$657.0M -$562.7M -$495.5M -$440.9M
Accumulated Other Comp. Income -$1.46M -$7.53M -$4.59M -$8.40M -$3.99M $5.42M -$2.45M -$1.44M -$286K $20K
Total Stockholders' Equity -$14.27M $22.77M $82.89M $295.0M $375.3M $498.2M $432.6M $366.5M $187.9M $136.2M
Total Equity -$14.27M $22.77M $82.89M $295.0M $375.3M $497.4M $432.7M $367.3M $187.9M $136.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Cash & Cash Equivalents $27.59M $20.95M $29.62M $38.34M $25.18M $41.92M $39.20M $27.79M
Cash & Short-Term Investments $27.59M $20.95M $29.62M $38.34M $25.18M $41.92M $39.20M $27.79M
Accounts Receivable, Net $873K $371K $523K $372K $366K $526K $10.50M $581K
Total Current Assets $37.11M $35.83M $44.08M $49.89M $37.60M $51.69M $58.13M $40.08M
Property, Plant & Equipment, Net $10.32M $11.04M $14.79M $15.73M $16.88M $17.89M $19.15M $20.62M
Goodwill -- -- -- -- -- $0 -- --
Intangible Assets -- -- -- -- -- $0 -- --
Other Non-Current Assets $870K $871K $871K $890K $882K $879K -- --
Total Non-Current Assets $22.85M $23.91M $44.57M $47.66M $48.57M $49.94M $53.13M $52.94M
Total Assets $59.97M $59.74M $88.64M $97.56M $86.17M $101.6M $111.3M $93.01M
Accounts Payable $19.31M $14.44M $15.56M $10.74M $18.20M $15.48M $19.79M $17.59M
Deferred Revenue (Current) $402K $899K $7.56M $7.56M $7.56M $7.56M $774K --
Total Current Liabilities $53.13M $42.47M $50.12M $47.66M $49.56M $45.80M $43.16M $39.01M
Deferred Revenue (Non-Current) $5.87M $5.87M $5.87M $5.87M $5.87M $5.87M -- --
Other Non-Current Liabilities $580K $580K $977K $962K $933K $933K $1.24M $1.22M
Total Non-Current Liabilities $25.79M $31.55M $32.27M $30.30M $31.70M $33.06M $28.97M $30.32M
Total Liabilities $78.92M $74.01M $82.40M $77.96M $81.26M $78.86M $72.13M $69.32M
Total Debt (incl. Leases) $19.33M $26.80M $25.42M $23.46M $24.88M $30.57M $27.73M $29.10M
Common Stock $4.14M $3.51M $3.22M $2.73M $2.25M $2.13M $2.09M $2.08M
Retained Earnings -$1.66B -$1.63B -$1.59B -$1.55B -$1.53B -$1.50B -$1.48B -$1.49B
Accumulated Other Comp. Income -$2.51M -$1.46M -$1.45M -$1.46M -$5.53M -$7.53M -$4.22M -$5.88M
Total Stockholders' Equity -$18.95M -$14.27M $6.24M $19.60M $4.91M $22.77M $39.13M $23.69M
Total Equity -$18.95M -$14.27M $6.24M $19.60M $4.91M $22.77M $39.13M $23.69M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$122.9M -$97.94M -$257.8M -$192.3M -$178.3M -$121.1M -$95.42M -$68.89M -$54.57M -$71.66M
Depreciation & Amortization $3.96M $5.11M $15.06M $12.11M $9.44M $5.68M $3.93M $2.36M $1.50M $997K
Stock-Based Compensation $9.08M $12.38M $27.36M $31.65M $32.96M $25.71M $19.33M $14.68M $9.09M $15.06M
Change in Receivables $155K $397K $2.75M $2.33M -$789K $31.68M -$32.24M -$1.33M $1.63M -$2.14M
Operating Cash Flow -$97.21M -$67.14M -$224.8M -$223.6M -$233.3M $169.9M -$144.4M $36.55M $11.18M -$65.88M
Capital Expenditure -$102K -$267K -$21.16M -$20.17M -$23.28M -$14.71M -$20.68M -$43.06M -$3.75M -$732K
Free Cash Flow -$97.31M -$67.41M -$246.0M -$243.8M -$256.5M $155.2M -$165.1M -$6.51M $7.43M -$66.61M
Acquisitions, Net -- -- -- -- -- $0 $0 -$75.65M $0 --
Purchases of Investments -- $0 -$59.55M -$277.4M -$338.2M -$570.8M -$443.7M -$451.2M -$252.3M -$218.6M
Investing Cash Flow -$102K $37.52M $153.5M $59.28M $248.2M -$271.6M -$59.80M -$178.1M -$77.40M $18.12M
Common Stock Issued $21.48M $21.86M $15.11M -- -- $2.02M $2.04M $1.48M $818K $1.11M
Financing Cash Flow $70.75M $28.38M $14.59M $84.66M $32.86M $153.1M $142.0M $231.7M $97.49M $337K
Net Change in Cash -$22.47M -$3.29M -$55.24M -$78.43M $47.54M $50.90M -$61.99M $90.59M $31.27M -$47.42M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income -$31.00M -$37.42M -$34.93M -$19.99M -$30.60M -$23.40M $10.67M -$36.13M
Depreciation & Amortization $719K $959K $989K $993K $1.02M $1.24M $1.22M $1.24M
Stock-Based Compensation $992K $2.13M $2.13M $2.23M $2.60M $3.28M $3.31M $3.06M
Change in Receivables -$502K $152K -$151K -$6.0K $160K $9.97M -$9.91M $110K
Operating Cash Flow -$19.28M -$24.40M -$28.50M -$18.16M -$26.15M -$3.35M $11.76M -$26.88M
Capital Expenditure -$13K -$14K -$64K -$24K $0 -$152K -$115K $0
Free Cash Flow -$19.30M -$24.42M -$28.56M -$18.18M -$26.15M -$3.50M $11.64M -$26.88M
Purchases of Investments -- -- -- -- -- $0 $0 $0
Investing Cash Flow -$13K -$14K -$64K -$24K $0 $1.32M $233K $127K
Common Stock Issued $23.35M $0 -$106K $21.59M $0 -$65K $0 $21.92M
Financing Cash Flow $26.70M $14.80M $19.20M $28.61M $8.13M $6.99M -$203K -$533K
Net Change in Cash $6.64M -$9.58M -$9.32M $13.16M -$16.74M $2.72M $12.91M -$27.55M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -306.5% -179.9% -155.5% -180.8% -165.6% -109.6% -102.7% -91.4% -154.1% -374.2%
Net Profit Margin -310.8% -169.4% -146.3% -172.8% -161.1% -102.4% -92.9% -80.9% -149.2% -369.6%
Return on Equity (ROE) -- -430.1% -311.1% -65.2% -47.5% -24.3% -22.0% -18.6% -29.0% -52.6%
Return on Assets (ROA) -205.8% -96.4% -156.0% -34.2% -24.7% -12.9% -14.9% -11.6% -19.0% -45.4%
Current Ratio 0.84x 1.13x 1.98x 2.69x 3.12x 4.60x 5.80x 5.23x 5.54x 11.25x
Quick Ratio 0.50x 0.93x 1.72x 2.79x 2.99x 4.50x 5.72x 5.16x 5.50x 2.03x
Debt to Equity -- 1.34x 0.46x 0.15x 0.13x 0.08x 0.10x -- -- --
Revenue Growth (YoY) -31.6% -67.2% +58.3% +0.5% -6.3% +15.4% +21.3% +131.0% +88.6% -51.0%
Operating Cash Flow Growth (YoY) -- -- -- -- -237.3% -- -495.1% +227.0% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -265.3% -- -- -187.7% -- --
5Y Revenue / Share Growth -83.9% -68.6% +16.0% +54.0% +178.6% +106.3% +77.5% +257.4% +101.8% +216.5%
10Y Revenue / Share Growth -66.9% -44.3% +314.5% +210.7% +781.8% +349.0% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Operating Margin -357.5% -306.5% -331.6% -76.9% -128.7% -179.9% -267.8% -2094.0%
Net Profit Margin -356.9% -310.8% -331.3% -77.5% -124.6% -169.4% -257.9% -2033.7%
Return on Equity (ROE) -- -- -1744.5% -323.0% -1619.4% -430.1% -344.6% -1053.9%
Return on Assets (ROA) -205.7% -205.8% -122.9% -64.9% -92.2% -96.4% -121.2% -268.4%
Current Ratio 0.70x 0.84x 0.88x 1.05x 0.76x 1.13x 1.35x 1.03x
Quick Ratio 0.54x 0.50x 0.60x 0.81x 0.52x 0.93x 1.15x 0.73x
Debt to Equity -- -- 4.07x 1.20x 5.07x 1.34x 0.71x 1.23x
Revenue Growth (YoY) -77.6% +88.4% -98.8% +5042.1% +1238.3% +269.8% +425.8% -94.8%
Operating Income Growth (YoY) -- -- -434.4% -- -- -- -- --
Net Income Growth (YoY) -- -- -427.3% -- -- -- -- --
EPS Growth (YoY) -- -- -320.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -342.4% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -345.3% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001001233) · from December 31, 2009 Data through March 31, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal